Leukodystrophy, Metachromatic: Clinical Trials

3 trials for Leukodystrophy, Metachromatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Completed 1, Terminated 1
Phase 21Completed 1

Follow Leukodystrophy, Metachromatic: new trials by email Literature Review of Leukodystrophy, Metachromatic trials Research Report on Leukodystrophy, Metachromatic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)
OTL-200 - Lysosomal Storage Diseases, Metachromatic Leukodystrophy
Phase 3Active not recruitingOrchard Therapeutics62022-01-172025-09-05
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
ALD-101 - Inherited Metabolic Diseases, Lysosomal Storage Disorders
Phase 3TerminatedAldagen402008-03-012014-07-08
Stem Cell Transplant for Inborn Errors of Metabolism
Stem Cell Transplant, Busulfan, Cyclophosphamide, Antithymocyte Globulin - Adrenoleukodystrophy, Metachromatic Leukodystrophy
Phase 2 / Phase 3CompletedMasonic Cancer Center, University of Minnesota1351995-01-012017-12-28

Narrower conditions

Adrenoleukodystrophy (2)  ·  Fucosidosis (2)  ·  Gangliosidosis, GM1 (2)  ·  Leukodystrophy, Globoid Cell (2)  ·  Lysosomal Storage Diseases (2)  ·  Sandhoff Disease (2)  ·  Tay-Sachs Disease (2)  ·  Canavan Disease (1)  ·  Gaucher Disease (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucolipidoses (1)  ·  Mucopolysaccharidoses (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis II (1)

Broader conditions

Brain Diseases (3)  ·  Brain Diseases, Metabolic (3)  ·  Brain Diseases, Metabolic, Inborn (3)  ·  Central Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Demyelinating Diseases (3)  ·  Genetic Diseases, Inborn (3)  ·  Hereditary Central Nervous System Demyelinating Diseases (3)  ·  Leukoencephalopathies (3)  ·  Lipid Metabolism Disorders (3)  ·  Lipid Metabolism, Inborn Errors (3)  ·  Lipidoses (3)  ·  Lysosomal Storage Diseases, Nervous System (3)  ·  Metabolic Diseases (3)  ·  Nervous System Diseases (3)

Interventions

Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Stem Cell Transplantation (1)

Sponsors

Aldagen (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Orchard Therapeutics (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

James Hinson, MD (1)  ·  Joanne Kurtzberg, MD (1)  ·  Paul Orchard, MD (1)

Results publications

PMID 21586746